A selective IDO1 inhibitor, KHK2455, improves efficacy of PD-L1 blockade by modulating both innate and adaptive immunity in a mouse melanoma model
Cancer Immunology, Immunotherapy · 19.12.2025 · 75 (1)
DOI: 10.1007/s00262-025-04232-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 19.12.2025. Verfasst von Masato Saito und 6 weiteren Autor:innen. Beteiligte Einrichtung: R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, Immunity, Innate, Adaptive Immunity, B7-H1 Antigen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- R&D Division, Kyowa Kirin Co., Ltd., Tokyo, Japan.
- School of Life Science and Technology, Institute of Science Tokyo, Tokyo, Japan. takuji@bio.titech.ac.jp.
- Metagen, Inc., Yamagata, Japan. takuji@bio.titech.ac.jp.
- Metagen Therapeutics, Inc., Yamagata, Japan. takuji@bio.titech.ac.jp.
- Digzyme, Inc., Tokyo, Japan. takuji@bio.titech.ac.jp.
Zitieren
APA
Saito, M., Kunieda, K., Ishii, T., Koshiba, S., Ohashi, R., Kanda, Y., & Yamada, T. (2025). A selective IDO1 inhibitor, KHK2455, improves efficacy of PD-L1 blockade by modulating both innate and adaptive immunity in a mouse melanoma model. Cancer Immunology, Immunotherapy, 75(1). https://doi.org/10.1007/s00262-025-04232-8
Vancouver
Saito M, Kunieda K, Ishii T, Koshiba S, Ohashi R, Kanda Y, et al. A selective IDO1 inhibitor, KHK2455, improves efficacy of PD-L1 blockade by modulating both innate and adaptive immunity in a mouse melanoma model. Cancer Immunology, Immunotherapy. 2025;75(1). doi:10.1007/s00262-025-04232-8
BibTeX
@article{Saito2025,
author = {Saito, Masato and Kunieda, Kana and Ishii, Toshihiko and Koshiba, Shoko and Ohashi, Rui and Kanda, Yutaka and Yamada, Takuji},
title = {A selective IDO1 inhibitor, KHK2455, improves efficacy of PD-L1 blockade by modulating both innate and adaptive immunity in a mouse melanoma model},
journal = {Cancer Immunology, Immunotherapy},
year = {2025},
volume = {75},
number = {1},
doi = {10.1007/s00262-025-04232-8}
}
EUVIMED